Home/Filings/4/0001169245-20-000016
4//SEC Filing

Burkhardt Glen 4

Accession 0001169245-20-000016

CIK 0001169245other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 6:38 PM ET

Size

8.0 KB

Accession

0001169245-20-000016

Insider Transaction Report

Form 4
Period: 2020-02-12
Burkhardt Glen
VP, Human Resources
Transactions
  • Award

    Employee Stock Option (right to buy)

    2020-02-12+55,00055,000 total
    Exercise: $5.19Exp: 2030-02-12Common Stock (55,000 underlying)
  • Award

    Employee Stock Option (right to buy)

    2020-02-12+20,00020,000 total
    Exercise: $5.19Exp: 2030-02-12Common Stock (20,000 underlying)
Footnotes (2)
  • [F1]The shares subject to the option shall vest in equal monthly installments over 48 months from February 12, 2020, subject to the reporting person's continued service through each such date.
  • [F2]One-fourth (1/4th) of the shares vest one year after the initial vesting date of March 15, 2019; the balance of the shares shall vest in a series of 36 successive equal monthly installments measured from the first anniversary of the initial vesting date, subject to the Reporting Person's continuous service as of each such date.

Issuer

PhaseBio Pharmaceuticals Inc

CIK 0001169245

Entity typeother

Related Parties

1
  • filerCIK 0001803271

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 6:38 PM ET
Size
8.0 KB